In vitro susceptibilities of common pediatric pathogens to LY163892

S. Shelton, J. D. Nelson

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against β-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.

Original languageEnglish (US)
Pages (from-to)268-270
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume32
Issue number2
StatePublished - 1988

Fingerprint

loracarbef
Cefaclor
Amoxicillin-Potassium Clavulanate Combination
Pediatrics
Moraxella (Branhamella) catarrhalis
Amoxicillin
Haemophilus influenzae
Streptococcus
Oral Administration
Escherichia coli
Anti-Bacterial Agents
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

In vitro susceptibilities of common pediatric pathogens to LY163892. / Shelton, S.; Nelson, J. D.

In: Antimicrobial Agents and Chemotherapy, Vol. 32, No. 2, 1988, p. 268-270.

Research output: Contribution to journalArticle

@article{d05c12e0c84e4cac8e3f1d1e634553b2,
title = "In vitro susceptibilities of common pediatric pathogens to LY163892",
abstract = "LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against β-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.",
author = "S. Shelton and Nelson, {J. D.}",
year = "1988",
language = "English (US)",
volume = "32",
pages = "268--270",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - In vitro susceptibilities of common pediatric pathogens to LY163892

AU - Shelton, S.

AU - Nelson, J. D.

PY - 1988

Y1 - 1988

N2 - LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against β-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.

AB - LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against β-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.

UR - http://www.scopus.com/inward/record.url?scp=0023903504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023903504&partnerID=8YFLogxK

M3 - Article

C2 - 3129989

AN - SCOPUS:0023903504

VL - 32

SP - 268

EP - 270

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -